Expectations and Experiences of Side Effects Among Adolescent Women Using Intramuscular and Subcutaneous Depot Medroxyprogesterone Acetate

UNCG Author/Contributor (non-UNCG co-authors, if there are any, appear on document)
Amanda Elizabeth Tanner, Associate Professor (Creator)
The University of North Carolina at Greensboro (UNCG )
Web Site: http://library.uncg.edu/

Abstract: Background: Intramuscular depot medroxyprogesterone acetate (DMPA-IM) has known physical side effects including changes in bleeding. A lower dose, subcutaneous formulation (DMPA-SC) is available with a similar side effect profile among adult women; however, side effect data are lacking among adolescent women. We compare DMPA-IM and DMPA-SC with respect to physical and sexual side effects among adolescent women, and describe changes in side effect expectations and experiences between first and second injections.

Additional Information

Journal of Pediatric and Adolescent Gynecology 23 (2), e63-e64.
Language: English
Date: 2010
published abstract, adolescent, contraceptives, side effects

Email this document to